Dataset Information

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.

ABSTRACT: The SARS-CoV-2 epidemic has rapidly spread outside China with major outbreaks occurring in Italy, South Korea, and Iran. Phylogenetic analyses of whole-genome sequencing data identified a distinct SARS-CoV-2 clade linked to travellers returning from Iran to Australia and New Zealand. This study highlights potential viral diversity driving the epidemic in Iran, and underscores the power of rapid genome sequencing and public data sharing to improve the detection and management of emerging infectious diseases.

SUBMITTER: Eden JS

PROVIDER: S-EPMC7147362 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.

Eden John-Sebastian JS Rockett Rebecca R Carter Ian I Rahman Hossinur H de Ligt Joep J Hadfield James J Storey Matthew M Ren Xiaoyun X Tulloch Rachel R Basile Kerri K Wells Jessica J Byun Roy R Gilroy Nicky N O'Sullivan Matthew V MV Sintchenko Vitali V Chen Sharon C SC Maddocks Susan S Sorrell Tania C TC Holmes Edward C EC Dwyer Dominic E DE Kok Jen J

Virus evolution 20200101 1

The SARS-CoV-2 epidemic has rapidly spread outside China with major outbreaks occurring in Italy, South Korea, and Iran. Phylogenetic analyses of whole-genome sequencing data identified a distinct SARS-CoV-2 clade linked to travellers returning from Iran to Australia and New Zealand. This study highlights potential viral diversity driving the epidemic in Iran, and underscores the power of rapid genome sequencing and public data sharing to improve the detection and management of emerging infectio ...[more]

PMID: 32296544

Similar Datasets

Project description:BackgroundThere is a lack of multicentre analyses of the spectrum of dermatologic illnesses acquired by Canadian travellers and immigrants. Our objective for this study was to provide a comprehensive, Canada-specific surveillance summary of travel-related dermatologic conditions in a cohort of returned Canadian travellers and immigrants.MethodsData for Canadian travellers and immigrants with a primary dermatologic diagnosis presenting to CanTravNet sites between September 2009 and September 2012 were extracted and analyzed. Data were collected using the GeoSentinel data platform. This network comprises 56 specialized travel and tropical medicine clinics, including 6 Canadian sites (Vancouver, Calgary, Toronto, Ottawa and Montréal), that contribute anonymous, de-linked, clinician- and questionnaire-based travel surveillance data on all ill travellers examined to a centralized Structure Query Language database. Results were analyzed according to reason for most recent ravel: immigration (including refugee); tourism; business; missionary/volunteer/research and aid work; visiting friends and relatives; and other, which included students, military personnel and medical tourists.ResultsDuring the study period, 6639 patients presented to CanTravNet sites across Canada and 1076 (16.2%) received a travel-related primary dermatologic diagnosis. Arthropod bites (n = 162, 21.5%), rash (n = 141, 18.7%), cutaneous larva migrans (n = 98, 13.0%), and skin and soft tissue infection (n = 92, 12.2%) were the most common dermatologic diagnoses or diagnostic bundles issued to returning Canadian tourists (n = 754, 70.1% of total sample). Patients travelling for the purpose of immigration (n = 63, 5.9%) were significantly more likely to require inpatient management of their dermatologic diagnoses (p < 0.001) than those travelling for other purposes.InterpretationThis analysis of surveillance data details the spectrum of travel-related dermatological conditions among returning Canadian travellers in this cohort, and provides an epidemiologic framework for Canadian physicians encountering these patients.

Dataset Information

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.

Publications

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure